Inpatient rehabilitation in multiple sclerosis: Do the benefits carry over into the community?

Neurology

Volumn 52, Issue 1, 1999, Pages 50-56

  Freeman, J A ^a   Langdon, D W ^a   Hobart, J C ^a   Thompson, A J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; EMOTIONAL STABILITY; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MALE; MULTIPLE SCLEROSIS; OCCUPATIONAL THERAPY; PATIENT COUNSELING; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOTHERAPY; QUALITY OF LIFE; TREATMENT OUTCOME; WELLBEING;

EID: 0032951917     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.1.50     Document Type: Article

References (34)

1. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 1997;42:236-244.
2. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;3;227-231
3. Lublin FD, Reingold SC for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.
4. Johnson J, Thompson AJ. Rehabilitation in a neuroscience centre: the role of expert assessment and selection. Br J Ther Rehabil 1996;3:303-308.
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
6. Granger CV, Cotter AC, Hamilton BB, Fiedler RC, Hens MM. Functional assessment scales: study of persons with multiple sclerosis. Arch Phys Med Rehabil 1990;71:870-875.
7. Harwood RH, Ebrahim S. Manual of the London Handicap Scale Nottingham: University of Nottingham, Department of Health Care of the Elderly, 1995.
8. Ware JE, Snow KK, Kosinski M, Gandek B SF-36 Heath Survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Centre, 1993.
9. Rabins PV, Brooks BR. Emotional disturbance in multiple sclerosis patients: validity of the General Health Questionnaire (GHQ). Psychol Med 1981;11:425-427.
10. La Rocca NG, Kalb RC. Efficacy of rehabilitation in multiple sclerosis. J Neurol Rehabil 1992;6:147-155.
11. Mathews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990; 300:230-235.
12. SPSS Incorporated. SPSS for Windows: base system user's guide. Release 6.0. Chicago: SPSS, 1993.
13. Weinshenker BG, Issa M, Baskerville J. Meta-analysis of the placebo-treated groups in clinical trials of progressive MS. Neurology 1996;46:1613-1619.
14. Thompson AJ. Rehabilitation of progressive neurological disorders: a worthwhile challenge. Curr Opm Neurol 1996;9:437-440.
15. Francabandera FL, Holland NJ, Wiesel-Levison P, Scheinberg LC Multiple sclerosis rehabilitation: inpatient versus outpatient. Rehabil Nursing 1988;13:251-253.
16. Aisen ML, Sevilla D, Fox N. Inpatient rehabilitation for multiple sclerosis. J Neurol Rehabil 1996;10:43-46.
17. Kidd D Thompson AJ. A prospective study of neurorehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:423-424
18. Feigenson JS, Scheinberg L, Catalano, M et al. The cost-effectiveness of multiple sclerosis rehabilitation: a model. Neurology 1981;31:1316-1322.
19. Greenspun B, Stineman M, Agri R. Multiple sclerosis and rehabilitation outcome. Arch Phys Med Rehabil 1987;68:434-437.
20. Carey RG, Seibert JH. Who makes the most progress in inpatient rehabilitation? An analysis of functional gain. Arch Phys Med Rehabil 1988;69:337-343.
21. Kidd D, Howard RS, Losseff NA, Thompson AJ. The benefit of inpatient neurorehabilitation in multiple sclerosis. Clin Rehabil 1995;9:198-203.
22. Cervera-Deval J, Morant-Guillen MP, Fenollosa-Vazquez P, Serra-Escorihuella M, Vilchez-Padilla J. Social handicaps of multiple sclerosis and their relation to neurological alterations. Arch Phys Med Rehabil 1994;75:1223-1227.
23. Harvey C. Economic costs of multiple sclerosis: how much and who pays? New York: National Multiple Sclerosis Society Research and Medical Programs, 1995.
24. Pfennings LEMA, Cohen L, Van der Ploeg HM. How do you measure and influence quality of life in multiple sclerosis. In: Thompson AJ, Polman CO, Hohlfeld R, eds. MS: clinical challenges and controversies. London: Martin Dunitz, 1997:295-311.
25. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. Health-related quality of life in people with multiple sclerosis undergoing inpatient rehabilitation. J Neurol Rehab 1996;3:185-194.
26. Brunet DG, Hopman WH, Singer MA, Edgar CM, MacKenzie TA. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci 1996;23:99-103.
27. Jonsson A, Dock J, Ravnborg MH. Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurol Scand 1996;93:229-235.
28. European Federation of Neurological Societies. Task force document on standards in neurological rehabilitation. Eur J Neurol 1997;4:325-331.
29. Shnek ZM, Foley FW, LaRocca NG, Smith CR, Halper J. Psychological predictors of depression in multiple sclerosis. J Neurol Rehabil 1995;9:15-23.
30. MacLaren J. Rehabilitation through advocacy and empowerment. Br J Ther Rehabil 1996;3:492-497.
31. Devins GM, Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H. Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis 1993;181:377-381.
32. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-1218.
33. Thompson AJ, Johnston SR, Harrison J, Sheil R, Burnard S. Developing essential services for people with multiple sclerosis: a model for co-ordinated community care. MS Management 1997;4:11-18.
34. Johnson KP. Exercise, drug treatment, and the optimal care of multiple sclerosis patients. Ann Neurol 1996;39:432-441.